News
New research has identified the gene Egr-1 as a critical regulator of immune balance, offering hope for autoimmune disease therapies.
1d
News-Medical.Net on MSNEgr-1 gene identified as crucial regulator of regulatory T cells in multiple sclerosisAutoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect ...
A team at the Peter Mac is planning for first-in-human trials in five years, hoping this new therapy will eschew the ...
CAR T-cell therapies are approved by the US Food and Drug Administration (FDA) to treat some kinds of lymphomas and leukemias, as well as multiple myeloma. CAR T-cell therapy is typically used after ...
The increasing demand for donor hearts presents both a critical challenge and a significant opportunity for innovation in ...
Two of Cytiva’s top executives offer updates on the company's $1.6 billion in expansion projects worldwide, all to meet growing market demand for its services from developers and manufacturers of ...
Research led by the Joldasbekov Institute of Mechanics and Engineering in Kazakhstan, reports that camel milk intake ...
From FDA approvals streamlining access to critical therapies to new breakthroughs in challenging malignancies, the field of ...
However, the relative contributions of IL‐2 and T cell receptor signaling to this process are unknown. Here, we show that IL‐2 signaling is required to maintain open chromatin at hundreds of gene ...
Explore how the ratio of pd-1+ treg to ctl and the presence of tertiary lymphoid structures can influence treatment outcomes ...
9d
Zacks Investment Research on MSNFDA Grants Accelerated Approval to Regeneron's Blood Cancer DrugRegeneron Pharmaceuticals, Inc. REGN obtained FDA approval for linvoseltamab-gcpt for the treatment of relapsed or refractory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results